PGNY Stock Summary and Trading Ideas (Progyny | NASDAQ:PGNY)

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Progyny trades on the NASDAQ stock market under the symbol PGNY.

As of August 10, 2026, PGNY stock price declined to $27.85 with 1,260,859 million shares trading.

PGNY has a beta of 0.09, meaning it tends to be less sensitive to market movements. PGNY has a correlation of 0.00 to the broad based SPY ETF.

PGNY has a market cap of $2.18 billion. This is considered a Mid Cap stock.

Last quarter Progyny reported $351 million in Revenue and $.55 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.08.

In the last 3 years, PGNY traded as high as $42.08 and as low as $13.39.

The top ETF exchange traded funds that PGNY belongs to (by Net Assets): IJR, VTI, IWM, VB, AVUV.

PGNY has underperformed the market in the last year with a price return of +20.8% while the SPY ETF gained +23.5%. However, in the short term, PGNY had mixed performance relative to the market. It has outperformed in the last 3 months, returning +45.4% vs +5.9% return in SPY. But in the last 2 weeks, PGNY shares have been beat by the market, returning -10.7% compared to an SPY return of +4.6%.

PGNY support price is $27.50 and resistance is $28.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PGNY shares will trade within this expected range on the day.